Craft

XBiotech

Stock Price

$7.2

2024-10-29

Market Capitalization

$234.4 M

2024-10-29

Revenue

$4 M

FY, 2022

XBiotech Summary

Company Summary

Overview
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology. Its technology allows the identification of the unique genetic information of immune antibodies from donor blood. This genetic information is used for the production of antibody therapies without modification. The company targets oncology, inflammatory conditions, and infectious diseases.
Type
Public
Status
Active
Founded
2005
HQ
Austin, TX, US | view all locations
Website
http://www.xbiotech.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • John Simard

    John Simard, Founder, President, Chief Executive Officer & Chairman

  • Sushma Shivaswamy

    Sushma Shivaswamy, Chief Scientific Officer

  • Qian Wu

    Qian Wu, Vice President of Quality Control

  • Norma I. Gonzalez

    Norma I. Gonzalez, Vice President of Quality

LocationsView all

1 location detected

  • Austin, TX HQ

    United States

    5217 Winnebago Ln

XBiotech Financials

Summary Financials

Net income (Q1, 2026)
($5.5M)
Cash (Q1, 2026)
$115.5M
EBIT (Q1, 2026)
($6.3M)

Footer menu